文献速递心血管技术与安全CTMRPETDSA

心血管影像中的放射生物学

Radiobiology in Cardiovascular Imaging.
PubMed 文献 · JACC Cardiovasc Imaging · 2016-01-01

本文综述心血管影像相关的放射生物学效应,重点讨论辐射诱发癌症的可能性,涉及线性无阈值剂量-反应模型及辐射兴奋效应等替代模型。诊断影像相关有效剂量约10 mSv(1 rem),此范围内可能效应为随机性且很大程度上是理论性的;罕见情况下心脏透视可致中度至重度皮肤损伤。

要点

  • 诊断影像有效剂量约10 mSv(1 rem)时,可能效应为随机性且很大程度上是理论性的。
  • 最值得注意的随机性效应是癌症风险的可能增加。
  • 罕见情况下心脏透视可致中度至重度皮肤损伤。

核心结论

  • 心血管影像与一系列放射生物学效应相关,诊断剂量范围内效应为随机性且很大程度上是理论性的,最值得注意的是癌症风险可能增加。

研究设计与样本

  • 综述,讨论心血管影像相关放射生物学,包括线性无阈值剂量-反应模型和辐射兴奋效应等替代模型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The introduction of ionizing radiation in medicine revolutionized the diagnosis and treatment of disease and dramatically improved and continues to improve the quality of health care. Cardiovascular imaging and medical imaging in general, however, are associated with a range of radiobiologic effects, including, in rare instances, moderate to severe skin damage resulting from cardiac fluoroscopy. For the dose range associated with diagnostic imaging (corresponding to effective doses on the order of 10 mSv [1 rem]), the possible effects are stochastic in nature and largely theoretical. The most notable of these effects, of course, is the possible increase in cancer risk. The current review addresses radiobiology relevant to cardiovascular imaging, with particular emphasis on radiation induction of cancer, including consideration of the linear nonthreshold dose-response model and of alternative models such as radiation hormesis.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Zanzonico P, Dauer L, Strauss HW, et al. Radiobiology in Cardiovascular Imaging. JACC Cardiovasc Imaging. 2016. PMID: 27931527. doi:10.1016/j.jcmg.2016.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。